Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Digestion
|
January 1, 1991
Determination of various molecular forms of cholecystokinin from canine mucosa by radioimmunoassay and bioassay
J Mössner, J M Zeeh, G Eberlein, et al.
Gastroenterology
|
May 1, 1997
Altered postprandial motility in chronic pancreatitis: role of malabsorption
P Layer, M R von der Ohe, J J Holst, et al.
Alimentary Pharmacology & Therapeutics
|
January 23, 2008
Impairment of health-related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety
S Haag, W Senf, W Häuser, et al.
The American Journal of Physiology
|
June 11, 1990
Molecular variants of cholecystokinin after endogenous stimulation in humans: a time study
V E Eysselein, G A Eberlein, W H Hesse, et al.
Pancreas
|
July 1, 1996
Inhibition of canine exocrine pancreatic secretion by peptide YY is mediated by PYY-preferring Y2 receptors
S Teyssen, D Grandt, E Niebergall-Roth, et al.
Regulatory Peptides
|
November 14, 1996
Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors
D Grandt, M Schimiczek, W Rascher, et al.
Biochemical and Biophysical Research Communications
|
August 24, 1992
Novel generation of hormone receptor specificity by amino terminal processing of peptide YY
D Grandt, S Teyssen, M Schimiczek, et al.
Peptides
|
January 1, 1990
Structural characterization of canine PYY
V E Eysselein, G A Eberlein, D Grandt, et al.
The American Journal of Physiology
|
February 11, 1990
Characterization of the major form of cholecystokinin in human intestine: CCK-58
V E Eysselein, G A Eberlein, M Schaeffer, et al.
European Journal of Pharmacology
|
October 14, 1994
[Pro34]peptide YY is a Y1-selective agonist at peptide YY/neuropeptide Y receptors
D Grandt, F Feth, W Rascher, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Digestion
|
January 1, 1991
Determination of various molecular forms of cholecystokinin from canine mucosa by radioimmunoassay and bioassay
J Mössner, J M Zeeh, G Eberlein, et al.
Gastroenterology
|
May 1, 1997
Altered postprandial motility in chronic pancreatitis: role of malabsorption
P Layer, M R von der Ohe, J J Holst, et al.
Alimentary Pharmacology & Therapeutics
|
January 23, 2008
Impairment of health-related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety
S Haag, W Senf, W Häuser, et al.
The American Journal of Physiology
|
June 11, 1990
Molecular variants of cholecystokinin after endogenous stimulation in humans: a time study
V E Eysselein, G A Eberlein, W H Hesse, et al.
Pancreas
|
July 1, 1996
Inhibition of canine exocrine pancreatic secretion by peptide YY is mediated by PYY-preferring Y2 receptors
S Teyssen, D Grandt, E Niebergall-Roth, et al.
Regulatory Peptides
|
November 14, 1996
Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors
D Grandt, M Schimiczek, W Rascher, et al.
Biochemical and Biophysical Research Communications
|
August 24, 1992
Novel generation of hormone receptor specificity by amino terminal processing of peptide YY
D Grandt, S Teyssen, M Schimiczek, et al.
Peptides
|
January 1, 1990
Structural characterization of canine PYY
V E Eysselein, G A Eberlein, D Grandt, et al.
The American Journal of Physiology
|
February 11, 1990
Characterization of the major form of cholecystokinin in human intestine: CCK-58
V E Eysselein, G A Eberlein, M Schaeffer, et al.
European Journal of Pharmacology
|
October 14, 1994
[Pro34]peptide YY is a Y1-selective agonist at peptide YY/neuropeptide Y receptors
D Grandt, F Feth, W Rascher, et al.
Page
of 5